0
0 (0%)
Vitro Biopharma, Inc. [VTRO]
Source:
Company Overview
Vitro Biopharma, Inc is an innovative biotechnology company targeting autoimmune diseases and inflammatory disorders, with an ancillary focus in the research services and cosmeceutical fields.
| Country | United States |
| Headquarters | denver, colorado |
| Phone Number | (855) 848-7627 |
| Industry | manufacturing |
| CEO | Christopher Furman |
| Website | www.vitrobiopharma.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0.4 |
| Operating Profit | $-1.8 |
| Net Income | $-2.8 |
| Net Cash | $-0.5 |
Profit Ratios
| Gross Margin | $0.4 |
| Operating Margin | -410.2 |
| Profit as % of Revenues | -12.6% |
| Profit as % of Assets | -59.5% |
| Profit as % of Stockholder Equity | 28.6% |
Management Effectiveness
| Return on Equity | 28.6% |
| Return on Assets | -63.8% |
| Turnover Ratio | 9.4% |
| EBITA | $-1.8 |
Balance Sheet and Cash Flow Measures
| Total Assets | $4.4 |
| Total Liabilities | $14.4 |
| Operating Cash Flow | $-0.4 |
| Investing Cash Flow | $-0 |
| Financing Cash Flow | $-0 |
